RE, Federica
 Distribuzione geografica
Continente #
NA - Nord America 2.053
AS - Asia 1.366
EU - Europa 1.259
SA - Sud America 274
AF - Africa 33
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.999
Nazione #
US - Stati Uniti d'America 1.990
SG - Singapore 617
IT - Italia 469
CN - Cina 290
BR - Brasile 230
DE - Germania 222
HK - Hong Kong 148
FI - Finlandia 106
VN - Vietnam 84
GB - Regno Unito 78
RU - Federazione Russa 65
UA - Ucraina 61
FR - Francia 60
TR - Turchia 55
IN - India 48
CA - Canada 34
CZ - Repubblica Ceca 33
IE - Irlanda 31
BD - Bangladesh 29
PL - Polonia 26
SE - Svezia 22
MX - Messico 20
ZA - Sudafrica 18
AR - Argentina 17
NL - Olanda 17
JP - Giappone 15
DK - Danimarca 13
IQ - Iraq 13
AU - Australia 12
BE - Belgio 12
ES - Italia 12
AT - Austria 11
ID - Indonesia 10
TH - Thailandia 10
LT - Lituania 8
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
PY - Paraguay 6
EG - Egitto 5
MA - Marocco 5
UZ - Uzbekistan 5
VE - Venezuela 5
CO - Colombia 4
GR - Grecia 4
IR - Iran 4
JO - Giordania 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CH - Svizzera 3
PA - Panama 3
CR - Costa Rica 2
IL - Israele 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
UY - Uruguay 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 4.999
Città #
Singapore 257
Ashburn 233
Chandler 167
Hong Kong 147
Brescia 135
Fairfield 134
New York 123
Munich 110
Beijing 91
Los Angeles 85
Seattle 69
Dallas 64
Helsinki 58
Ann Arbor 54
Woodbridge 54
Wilmington 48
Jacksonville 47
Milan 47
Des Moines 46
Houston 46
Princeton 45
Istanbul 40
Cambridge 39
Boardman 37
Shanghai 36
Turku 35
Ho Chi Minh City 33
Dublin 31
The Dalles 27
São Paulo 26
Brno 25
Redondo Beach 24
San Francisco 24
Chicago 23
Hanoi 19
Moscow 19
Pune 19
Frankfurt am Main 16
Santa Clara 16
Boston 15
Toronto 15
Warsaw 15
Rome 14
Buffalo 13
Johannesburg 13
San Diego 13
Tokyo 13
Brussels 12
Helsingør 12
Atlanta 11
Brooklyn 11
Denver 11
Genoa 11
London 11
Nuremberg 11
Orem 11
Poplar 11
Montreal 10
Romola 10
Lappeenranta 9
Wroclaw 9
Adelaide 8
Charlotte 8
Düsseldorf 8
Mexico City 8
Stockholm 8
Barlassina 7
Bosio 7
Dearborn 7
Gorlago 7
Olomouc 7
Phoenix 7
Tianjin 7
Bologna 6
Brasília 6
Chennai 6
Curitiba 6
Jakarta 6
Manchester 6
Amsterdam 5
Bangkok 5
Bergamo 5
Biên Hòa 5
Florence 5
Querétaro 5
Salò 5
Tashkent 5
Amman 4
Annapolis 4
Athens 4
Baghdad 4
Belo Horizonte 4
Breganze 4
Cairo 4
Fortaleza 4
Guangzhou 4
Haiphong 4
Lauterbourg 4
Nanjing 4
Osimo 4
Totale 3.027
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 185
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 179
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 168
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 154
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 147
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 139
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 137
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 136
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 130
Impedance-based monitoring of mesenchymal stromal cell three-dimensional proliferation using aerosol jet printed sensors: A tissue engineering application 127
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 126
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 125
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 120
Mineralization of 3D Osteogenic Model Based on Gelatin-Dextran Hybrid Hydrogel Scaffold Bioengineered with Mesenchymal Stromal Cells: A Multiparametric Evaluation 112
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 111
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 110
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 107
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 106
Chitosan-based scaffold counteracts hypertrophic and fibrotic markers in chondrogenic differentiated mesenchymal stromal cells 104
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 96
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 96
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 93
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 93
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 92
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis 92
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 89
Bone Regeneration Using Mesenchymal Stromal Cells and Biocompatible Scaffolds: A Concise Review of the Current Clinical Trials 87
Hybrid Core-Shell Polymer Scaffold for Bone Tissue Regeneration 87
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 86
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 86
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 83
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 82
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 80
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 79
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 78
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 77
Hydrogel-chitosan and polylactic acid-polycaprolactone bioengineered scaffolds for reconstruction of mandibular defects: a preclinical in vivo study with assessment of translationally relevant aspects 76
Bone regeneration improves with mesenchymal stem cell derived extracellular vesicles (Evs) combined with scaffolds: A systematic review 76
Development of a Preclinical Double Model of Mandibular Irradiated Bone and Osteoradionecrosis in New Zealand Rabbits 74
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 74
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 71
New Poly(lactic acid)-Hydrogel Core-Shell Scaffolds Highly Support MSCs' Viability, Proliferation and Osteogenic Differentiation 69
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 67
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 65
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 64
In Vitro Biocompatibility Assessment of Bioengineered PLA-Hydrogel Core–Shell Scaffolds with Mesenchymal Stromal Cells for Bone Regeneration 64
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 62
Gelatin-Based Scaffolds with Carrageenan and Chitosan for Soft Tissue Regeneration 59
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 58
Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable? 54
Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending? 44
Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patient 37
Polysaccharides on gelatin-based hydrogels differently affect chondrogenic differentiation of human mesenchymal stromal cells 37
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 24
Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML) 5
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 5
Totale 5.084
Categoria #
all - tutte 27.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021256 0 0 0 0 0 55 25 28 39 44 48 17
2021/2022272 28 11 12 24 13 19 13 19 15 38 28 52
2022/2023438 47 31 15 50 39 74 4 46 65 9 25 33
2023/2024579 22 15 44 28 51 139 31 31 69 16 16 117
2024/20251.551 40 49 26 164 116 86 130 67 257 126 276 214
2025/20261.602 242 274 187 378 340 181 0 0 0 0 0 0
Totale 5.084